Your cart is currently empty!
Enclomiphene Citrate is a selective estrogen receptor modulator (SERM) that is widely researched for its ability to increase endogenous testosterone production by blocking estrogen receptors. This mechanism makes Enclomiphene a valuable compound in studies focused on hormonal regulation and fertility. Researchers frequently compare Enclomiphene with other Hormone Modulators such asCabergoline andPramipexole to explore its effectiveness in managing hormone levels and its potential applications in testosterone regulation. These comparisons help provide a broader understanding of how different hormone modulators impact overall hormone balance.
Enclomiphene Citrate is primarily studied for its role in stimulating testosterone production while minimizing the effects of estrogen, making it beneficial in research related to male fertility and hormone therapy. Researchers often study Enclomiphene in conjunction with other Hormone Modulators likeCabergoline, which is known for its dopamine agonist properties, andPramipexole, which impacts prolactin levels, to evaluate their combined effects on hormone regulation. This integration allows researchers to explore how Enclomiphene influences testosterone levels in the presence of compounds that affect various aspects of endocrine function.
Enclomiphene Citrate is typically administered in 25mg doses in research environments. Proper preparation and dosing protocols are crucial for obtaining reliable results, especially when comparing its effects with other Hormone Modulators likeCabergoline andPramipexole. Researchers may vary dosages to understand the interaction between Enclomiphene’s role as a SERM and the effects of other modulators on hormone balance and fertility.
Store Enclomiphene Citrate in a cool, dry place, and handle it with care according to laboratory safety standards. This product is strictly for research purposes and not for human consumption. Enclomiphene is often stored alongside other hormone-related compounds, includingCabergoline andPramipexole, to maintain stability and ensure the integrity of the compound during extended research periods.